• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BMP Medical Expands Sterling, Massachusetts Facility

    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

    Environmental Sustainability Becoming Increasingly Important to Medtech Industry

    Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board

    Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.

    Fusion Biotec Inc.

    Medbio LLC

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.

    Fusion Biotec Inc.

    Medbio LLC

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    3 Critical Considerations for U.S. Medical Device Commercialization

    The step-by-step process of working with the FDA to bring a medical device to the U.S.

    3 Critical Considerations for U.S. Medical Device Commercialization
    Related CONTENT
    • MEDICAL & BIOTECH MANUFACTURING
    • Breakthrough Device Designation Granted for New Neuromodulation Platform
    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    • Accu-Tube Appoints Matthew Haddle as CEO
    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    Michael Lynch, Managing Consultant, Intertek05.18.18
    Bringing medical devices to market in the U.S. is a complex process. Products must meet general safety and quality regulations, as well as requirements set by the U.S. Food and Drug Administration (FDA). To navigate the process successfully, manufacturers must be prepared to classify the device, prepare and complete a premarket submission, and register and list with the administration. Let’s take a closer look at the step-by-step process of working with the FDA to bring a medical device to the U.S.

    1. Device Classification
    To start, a manufacturer must determine how a device will be classified. A device’s class is based on three fundamental criteria: the risk it poses to the patient and/or user, its intended use, and its indications for use. These factors determine a device’s and it is brought to market moving forward. There are three classes of medical devices in the U.S.:

    • Class I: These devices pose the lowest risk and thus have the least amount of regulation attached to them. They are subject only to general controls. Manual toothbrushes, elastic bandages, and enema kits are all examples of Class I devices. According to the FDA, 47 percent of medical devices are Class I; of those, 95 percent are exempt from the regulatory process.1
    • Class II: Devices in this class pose moderate risk and are subject to both general and special controls to prove their safety and efficacy. Examples of Class II devices include non-invasive blood pressure monitors, powered wheelchairs, and most pregnancy test kits. About 43 percent of medical devices fall into this class.1 Some Class II devices are exempt from premarket approval and the regulatory process, depending on limitations on the exemptions.
    • Class III: As more complex devices, these products pose the highest risk and are subject to the highest level of scrutiny—general controls, special controls, and the requirement to obtain premarket approval. They have more stringent requirements to illustrate safety and efficacy. Examples of Class III devices include heart valves, implants, and external defibrillators. About 10 percent of medical devices fall into this class.1

    In addition to the inherent risks of a device, classification also depends on the device’s intended use and indications for use. As mentioned above, all device classes are subject to general controls established by the Food, Drug, and Cosmetic Act. However, there are additional considerations for specific classifications. Premarket approvals are required for Class III devices, as well as Class I and Class II devices that are not exempt. For these, a premarket notification submission is required for marketing of the product.

    2. Premarket Submission
    After properly classifying a device, the next step is to select the correct premarket submission. There are four common types of premarket submissions, each with different conditions and obligations.

    • 510(k) Premarket Notification: The purpose of the 510(k) is to demonstrate the device is “substantially equivalent” to a predicate device in terms of intended use, technological characteristics, and performance testing, as needed. Most Class II devices require a 510(k), as do some Class 1 products. Others are exempt if they do not exceed the limitations of exemptions in .9 of the device classification regulation chapters. When submitting a 510(k), it is necessary to compare the device to one or more similar legally marketed devices, and to both make and support the substantial equivalence claims. Once the FDA determines the device to be substantially equivalent, the product can be marketed in the U.S.
    • Premarket Approval (PMA): A PMA is the most stringent premarket submission, requiring the sponsor to provide valid scientific evidence demonstrating reasonable assurance of safety and effectiveness for the device’s intended use. Most Class III medical devices require a PMA, given their higher level of risk and intended use. Approval is based on illustrating that the device is safe and effective for its intended use(s) via sufficient valid scientific evidence. An approved PMA is, essentially, a private license granting the applicant/owner permission to market the device. The owner can then authorize use of its data by another.
    • De Novo Evaluation of Automatic Class III Designation: The De Novo process provides a means to classify novel medical devices as Class I or Class II when there is no legally marketed predicate device. The FDA developed this designation to provide an alternative for Class I and Class II devices that were automatically classified as Class III after receiving an “not substantially equivalent” (NSE) determination response to a 510(k) submission.
    • Humanitarian Device Exemption (HDE): An HDE applies specifically to devices intended to benefit patients in treatment of rare diseases or conditions (affects fewer than 200,000 people in the U.S.). For a device to qualify for an HDE, a sponsor must obtain a designation for the product as a Humanitarian Use Device (HUD), which is approved through application to FDA’s Office of Orphan Products Development (OOPD). An HDE submission is similar to a PMA in form and content, but is exempt from the PMA’s effectiveness requirements. The sponsor is also required to demonstrate that no comparable devices are available to treat or diagnose the disease or condition, and that they could not otherwise bring the device to market.

    When preparing a premarket submission, it’s important to know the appropriate information to include given the device’s classification. Manufacturers should also objectively consider the level of risk associated with their devices. Submissions for high-risk devices require more information, including clinical and usability data. In contrast, submissions for low-risk devices may be cleared with nonclinical performance and bench tests.

    Most PMAs and some HDEs, 510(k)s, and De Novos require clinical evidence. If a clinical study is to take place, the study sponsor may need to obtain approval from the FDA for an Investigational Device Exemption (IDE). In addition, any studies must be approved by the appropriate Institutional Review Board (IRB). Along with these approvals, any clinical studies must comply with all applicable IDE regulations and good clinical practices (GCPs).

    All Class II and Class III devices must be designed in accordance with design controls under the Quality System Regulation (21 CFR 820.30). While the FDA establishes these requirements for Class II and Class III products, some Class I devices are exempt entirely from design controls. Additionally, the labeling for the device must be written according to labeling regulations and included with the submission.

    After compiling the appropriate information, the next step is to send the premarket submission to the FDA for review. Submissions must include an electronic copy in the form of a CD, DVD, or flash drive and, in the case of a 510(k) or PMA, an associated user fee. The FDA then conducts an administrative review to determine if the submission is sufficiently complete. During this review, FDA staff communicates with applicants to increase the efficiency of the process.

    The review time varies depending on the type of submission. An initial traditional or modular PMA typically has a review time of 140 days for manufacturing section review and site inspection. Traditional 510(k) submissions require 90 days for review. Major or minor changes, deficiencies or issues, and requests for additional information can all lead to delays and additional review time.

    3. Establishment Registration and Device Listing
    The last step is to register the establishment and list the device with the FDA. If a device requires premarket clearance or approval prior to marketing (i.e., the device is not exempt), the facility must wait until it receives FDA clearance or approval before registering and listing. Registration of a device establishment, assignment of a registration number, or listing of a medical device does not in any way denote clearance or approval of the establishment or its products by the FDA.

    When conducting inspections, the FDA reserves priority for manufacturers with pending PMA approval, Class III manufacturers that have never been inspected, compliance follow up/for cause inspections, and manufacturers of high-risk devices. Class III high-risk device manufacturers should expect an FDA inspection every two years. No additional fees are required for FDA inspections.

    Bringing medical devices to market in the U.S. can be a lengthy, complicated process, but one that can be done. Keeping in mind the various steps and options for a device can help in preparations. Take some time to learn the different classes, premarket submission options, and requirements and make sure to plan accordingly. Taking these into considerations can make a big difference in the successful launch of a device.

    Reference
    1 U.S. Food and Drug Administration. Learn if a Medical Device Has Been Cleared by FDA for Marketing. https://www.fda.gov/MedicalDevices/ResourcesforYou/Consumers/ucm142523.htm Accessed January 30, 2018.

    Related Searches
    • blood pressure
    • testing
    • ul
    • quality
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products
    CE Mark Granted to Predictive Software for Kidney Allograft Survival CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    OmniVision Debuts Industry’s First 8 Megapixel Medical-Grade Image Sensors OmniVision Debuts Industry’s First 8 Megapixel Medical-Grade Image Sensors
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    Babson Diagnostics Raises $31 Million in Series B Funding Babson Diagnostics Raises $31 Million in Series B Funding
    Paragonix Launches Global Registry for Studying Donor Lung Preservation Paragonix Launches Global Registry for Studying Donor Lung Preservation
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • Breakthrough Device Designation Granted for New Neuromodulation Platform

      Breakthrough Device Designation Granted for New Neuromodulation Platform

      In a pilot study treating refractory epilepsy with Neuroelectrics’ Starstim platform, patients experienced a 44 percent median reduction in seizure frequency.
      Business Wire 09.22.21

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21


    • Tubing & Extrusion
      Accu-Tube Appoints Matthew Haddle as CEO

      Accu-Tube Appoints Matthew Haddle as CEO

      Haddle has a track record of leading organizations through strategic expansions across the medical device, aerospace, and industrial sectors.
      Accu-Tube 09.22.21

    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    Loading, Please Wait..

    Trending
    • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
    • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Tandem Diabetes Completes Deal For AMF Medical
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    • Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    • Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board
    • Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login